SALT LAKE CITY, April 25, 2018 -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its third quarter ended March 31, 2018, after the stock market closes on Wednesday, May 9, 2018. The Company will hold an investor conference call at 2:30 p.m. Mountain Daylight Time (4:30 p.m. Eastern Daylight Time) that same day.
Investors interested in participating in the live call can dial (800) 239-9838 from the U.S. International callers can dial (323) 794-2551. A telephone replay will be available approximately two hours after the call concludes and will be available through Wednesday, May 16, 2018, by dialing (844) 512-2921 from the U.S. and entering confirmation code 1443602, or (412) 317-6671 from international locations, and entering confirmation code 1443602.
There also will be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at http://investor.lifevantage.com/events-and-presentations. The webcast will be archived for approximately 30 days.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq:LFVN) is a pioneer in Nutrigenomics - a new science dedicated to cracking the human aging code. The company is engaged in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin care products, including Protandim®, a scientifically-validated dietary supplement; TrueScience®, a line of Nrf2 infused skin care products; Petandim™ for Dogs, a companion pet supplement formulated to combat oxidative stress in dogs; Axio® Smart Energy Drink mixes; PhysIQ™, a Smart Weight Management System; and Omega+, a 3-in-1 fish oil supplement. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contact:
Scott Van Winkle
Managing Director, ICR
(617) 956-6736
[email protected]


Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal 



